Table II.

Cox multivariate regression analysis of 302 pancreatic cancer patients.

Parameter	DF	Wald Chi-square test	P-value	Hazard ratio (95% CI)
Gender	1	0.03	0.855	1.03 (0.75–1.41)
Age	1	0.42	0.517	0.91 (0.69–1.21)
Site of primary cancer	1	2.38	0.123	1.25 (0.94–1.66)
Stage	1	13.60	0.000	1.46 (1.19–1.78)
Treatment	1	13.93	0.000	0.51 (0.36–0.73)
Total bilirubin	1	0.17	0.678	0.93 (0.65–1.33)
Direct bilirubin	1	2.45	0.117	1.38 (0.92–2.06)
Glutamic-pyruvic transaminase	1	0.05	0.825	0.94 (0.56–1.58)
Glutamic-oxalacetic transaminase	1	0.00	0.970	0.99 (0.60–1.63)
Albumin	1	6.10	0.014	0.62 (0.42–0.91)
Blood urea nitrogen	1	9.81	0.002	0.43 (0.25–0.73)
Serum creatinine	1	0.60	0.437	0.83 (0.53–1.32)
Lactate dehydrogenase	1	2.57	0.109	1.31 (0.94–1.82)
Blood glucose	1	3.59	0.058	0.57 (0.31–1.02)
Hemoglobin	1	1.10	0.295	0.82 (0.56–1.20)
White blood cells	1	6.92	0.009	1.49 (1.11–2.01)
Platelets	1	3.94	0.047	0.73 (0.53–1.00)
CEA	1	0.32	0.573	1.11 (0.77–1.59)
CA19-9	1	4.54	0.033	1.53 (1.04–2.25)
CA125	1	1.88	0.171	1.86 (0.77–4.50)
CA15-3	1	0.32	0.574	1.22 (0.61–2.41)
CA72-4	1	0.70	0.404	0.68 (0.27–1.69)
CA50	1	0.01	0.924	0.96 (0.45–2.05)
CA242	1	0.81	0.370	0.63 (0.24–1.72)